NCT00029900View on ClinicalTrials.gov

ADI-PEG in Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

August 31, 2003

Conditions
MelanomaNeoplasm Metastasis
Interventions
DRUG

ADI PEG

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00029900 - ADI-PEG in Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter